Ying Chen

Ying Chen

Director Director DIN 09270280
DIN 09270280 First appointment Oct 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2021
Shareholding value Locked Premium profile

About Ying Chen

Ying Chen has 4 years in corporate governance. Formerly with 1 company, such as Bayer Zydus Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09270280
Primary Designation Director
First Appointment 01 Oct 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Bayer Zydus Pharma Private Limited U24233MH2011PTC213118
Additional Director 01 Oct 2021 2011 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bayer Zydus Pharma Private Limited
Premium access

Shareholding and investment profile for Ying Chen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ying Chen

Ying Chen has 4 years in corporate governance. Formerly with 1 company, such as Bayer Zydus Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Ying Chen is associated with 0 companies as a director.

Ying Chen has expertise in General Business.

Ying Chen has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available